An experimental drug developed at Northwestern University has demonstrated further promise as an early intervention for ...
New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...
A study of blood-based markers for Alzheimer’s disease in Norway confirms earlier estimates, and may show how education level ...
A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A new experimental drug from ...
People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.
Major Alzheimer’s breakthroughs in 2025 include new FDA-approved blood tests, at-home treatments, and lifestyle research showing cognitive benefits for older adults.
Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.
A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than ...
Research published in the Journal of Alzheimer's Disease suggests findings could transform emergency protocols for the 2.5 ...
A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer's disease.
One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many ...
New Alzheimer's drug Leqembi offers hope to Oklahoma couple as they celebrate 50 years of marriage and fight against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results